ScoreWhy is Par Drugs & Chemicals Ltd ?
1
The company is Net-Debt Free
2
Poor long term growth as Net Sales has grown by an annual rate of 10.49% and Operating profit at 2.19% over the last 5 years
- PAT(Q) At Rs 4.71 cr has Grown at 43.7% (vs previous 4Q average)
- NET SALES(Q) Highest at Rs 31.28 cr
- PBDIT(Q) Highest at Rs 6.38 cr.
3
With ROE of 12.9, it has a Fair valuation with a 1.5 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -100.00%, its profits have risen by 2.3% ; the PEG ratio of the company is 5
4
Majority shareholders : Promoters
5
Below par performance in long term as well as near term
- Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Par Drugs & Che. should be less than 10%
- Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Par Drugs & Che. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Par Drugs & Che.
15.22%
0.28
55.04%
Sensex
-10.5%
-0.78
13.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.49%
EBIT Growth (5y)
2.19%
EBIT to Interest (avg)
15.74
Debt to EBITDA (avg)
0.39
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
1.12
Tax Ratio
24.33%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.09%
ROCE (avg)
29.27%
ROE (avg)
14.69%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
17
Price to Book Value
1.50
EV to EBIT
7.80
EV to EBITDA
6.33
EV to Capital Employed
1.80
EV to Sales
1.16
PEG Ratio
4.98
Dividend Yield
NA
ROCE (Latest)
19.15%
ROE (Latest)
12.94%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
PAT(Q)
At Rs 4.71 cr has Grown at 43.7% (vs previous 4Q average
NET SALES(Q)
Highest at Rs 31.28 cr
PBDIT(Q)
Highest at Rs 6.38 cr.
PBT LESS OI(Q)
Highest at Rs 5.39 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Par Drugs & Che.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 5.39 cr has Grown at 62.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 3.32 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 4.71 cr has Grown at 43.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 3.28 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 31.28 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 31.28 cr has Grown at 20.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 25.92 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 6.38 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 5.39 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
